Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods

John N Galgiani, J. Reiser, C. Brass, A. Espinel-Ingroff, M. A. Gordon, T. M. Kerkering

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Three groups of isolates, each comprising four isolates of Candida species, were selected for their diversity of susceptibilities to amphotericin B, flucytosine, or ketoconazole. The isolates were distributed in duplicate and in blinded fashion to three laboratories where a total of eight procedures were performed for each drug. From the decoded results, intralaboratory variability among replicate determinations was found usually to fall within a fourfold range. Interlaboratory variation, however, was 16-fold or greater for all isolates, ranging to 50,000-fold differences for some isolates. Relative susceptibilities of isolates within each method could be determined in 11 of the 24 drug-method combinations and agreed with the reference rank order in all but one instance. Our findings underscore the lack of agreement among laboratories for the susceptibility testing of yeasts but indicate that such differences could likely be resolved by standardization without loss of clinical value.

Original languageEnglish (US)
Pages (from-to)1343-1347
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume31
Issue number9
StatePublished - 1987

Fingerprint

Antifungal Agents
Candida
Flucytosine
Ketoconazole
Amphotericin B
Drug Combinations
Yeasts
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. / Galgiani, John N; Reiser, J.; Brass, C.; Espinel-Ingroff, A.; Gordon, M. A.; Kerkering, T. M.

In: Antimicrobial Agents and Chemotherapy, Vol. 31, No. 9, 1987, p. 1343-1347.

Research output: Contribution to journalArticle

Galgiani, John N ; Reiser, J. ; Brass, C. ; Espinel-Ingroff, A. ; Gordon, M. A. ; Kerkering, T. M. / Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. In: Antimicrobial Agents and Chemotherapy. 1987 ; Vol. 31, No. 9. pp. 1343-1347.
@article{b6da2825a1b04e17bd9deb454fb51cb6,
title = "Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods",
abstract = "Three groups of isolates, each comprising four isolates of Candida species, were selected for their diversity of susceptibilities to amphotericin B, flucytosine, or ketoconazole. The isolates were distributed in duplicate and in blinded fashion to three laboratories where a total of eight procedures were performed for each drug. From the decoded results, intralaboratory variability among replicate determinations was found usually to fall within a fourfold range. Interlaboratory variation, however, was 16-fold or greater for all isolates, ranging to 50,000-fold differences for some isolates. Relative susceptibilities of isolates within each method could be determined in 11 of the 24 drug-method combinations and agreed with the reference rank order in all but one instance. Our findings underscore the lack of agreement among laboratories for the susceptibility testing of yeasts but indicate that such differences could likely be resolved by standardization without loss of clinical value.",
author = "Galgiani, {John N} and J. Reiser and C. Brass and A. Espinel-Ingroff and Gordon, {M. A.} and Kerkering, {T. M.}",
year = "1987",
language = "English (US)",
volume = "31",
pages = "1343--1347",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods

AU - Galgiani, John N

AU - Reiser, J.

AU - Brass, C.

AU - Espinel-Ingroff, A.

AU - Gordon, M. A.

AU - Kerkering, T. M.

PY - 1987

Y1 - 1987

N2 - Three groups of isolates, each comprising four isolates of Candida species, were selected for their diversity of susceptibilities to amphotericin B, flucytosine, or ketoconazole. The isolates were distributed in duplicate and in blinded fashion to three laboratories where a total of eight procedures were performed for each drug. From the decoded results, intralaboratory variability among replicate determinations was found usually to fall within a fourfold range. Interlaboratory variation, however, was 16-fold or greater for all isolates, ranging to 50,000-fold differences for some isolates. Relative susceptibilities of isolates within each method could be determined in 11 of the 24 drug-method combinations and agreed with the reference rank order in all but one instance. Our findings underscore the lack of agreement among laboratories for the susceptibility testing of yeasts but indicate that such differences could likely be resolved by standardization without loss of clinical value.

AB - Three groups of isolates, each comprising four isolates of Candida species, were selected for their diversity of susceptibilities to amphotericin B, flucytosine, or ketoconazole. The isolates were distributed in duplicate and in blinded fashion to three laboratories where a total of eight procedures were performed for each drug. From the decoded results, intralaboratory variability among replicate determinations was found usually to fall within a fourfold range. Interlaboratory variation, however, was 16-fold or greater for all isolates, ranging to 50,000-fold differences for some isolates. Relative susceptibilities of isolates within each method could be determined in 11 of the 24 drug-method combinations and agreed with the reference rank order in all but one instance. Our findings underscore the lack of agreement among laboratories for the susceptibility testing of yeasts but indicate that such differences could likely be resolved by standardization without loss of clinical value.

UR - http://www.scopus.com/inward/record.url?scp=0023629082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023629082&partnerID=8YFLogxK

M3 - Article

VL - 31

SP - 1343

EP - 1347

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -